MA

Mahsa Dolatshahi

Mahsa Dolatshahi (MD-MPH)

Contact info:




Education:


Tehran University of Medical Sciences, Tehran, Iran


Medical Doctor (2014-2021)


Master of Public Health (2017-2021)



Farzanegan High School, Khorramabad, Iran


Natural Sciences Diploma, first rank in high school (2006-2013)


4th rank of Natural Sciences in annual national university entrance exam (2014)


Experience



2016-2021


Active member and executive manager of NeuroImaging Network (NIN) at Universal Scientific Education and Research Network (USERN)



2015-2021


Active member of Interdisciplinary Neuroscience Research Program (INRP) at Students' Scientific Research Center (SSRC),
Tehran University of Medical Sciences (TUMS)



2020-2021


Research associate at Iranian Center of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences



2018-2019


Manager of research deputy at Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences (TUMS)



2016-2017


Research management at neuropsychology association (NPA) at Students' Scientific Research Center (SSRC),
Tehran University of Medical Sciences (TUMS)



Honors & Awards



  • The Most Active Researcher Prize at Students’ Scientific Research Center (SSRC) (2019)
  • Bronze Medal in 11th national Scientific Thinking in Basic Sciences Olympiad (2019)
  • 4th rank of Natural Sciences in annual national university entrance exam (2014)

Skills



  • Clinical reasoning: intermediate
  • English speaking/writing skills: professional
  • Study design: high-intermediate
  • Scientific writing: high-intermediate
  • Statistical analysis and interpretation: SPSS (intermediate), R (intermediate)
  • Systematic review and meta-analysis: high-intermediate
  • Neuroimaging data analysis (FSL & ExploreDTI) and interpretation: DTI (intermediate), fMRI (basic)
  • Programming: Python (basic) & R (basic)
  • Research management: intermediate
  • Teamwork: professional

Publications



  1. Dolatshahi, M., Sabahi, M., Shahjouei, S., Koza, E., Abedi, V., & Zand, R. (2022, 2022/01/01). Intravenous thrombolysis in ischemic stroke patients with a prior intracranial hemorrhage: a meta-analysis. Therapeutic Advances in Neurological Disorders, 15, 17562864221074144. https://doi.org/10.1177/17562864221074144
  2. Ekraminasab, S., Dolatshahi, M., Sabahi, M., Mardani, M., & Rashedi, S. (2022, 2022/01/05). The Interactions between Adipose Tissue Secretions and Parkinson’s disease; The Role of Leptin. European Journal of Neuroscience, n/a(n/a).
    https://doi.org/https://doi.org/10.1111/ejn.15594
    (The first two authors had equal contribution)
  3. Davoody, S., Goeschl, S., Dolatshahi, M., Davari-Ashtiani, R., Saffarpour, R., Sodeifian, F., & Brand, S. (2022). Relation between ADHD and COVID-19: A Narrative Review to Guide Advancing Clinical Research and Therapy. Iranian Journal of Psychiatry, 17(1).
  4. Dolatshahi, M., Ashraf-Ganjouei, A., Wu, I. W., Zhang, Y., Aarabi, M. H., & Tosun, D. (2021, 2021/11/15/). White matter changes in drug-naïve Parkinson's disease patients with impulse control & probable REM sleep behavior disorders. Journal of the Neurological Sciences, 430, 120032. https://doi.org/https://doi.org/10.1016/j.jns.2021.120032
  5. Farshbafnadi, M., Kamali Zonouzi, S., Sabahi, M., Dolatshahi, M., & Aarabi, M. H. (2021, 2021/10/15/). Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors. Experimental Gerontology, 154, 111507. https://doi.org/https://doi.org/10.1016/j.exger.2021.111507
  6. Sanjari Moghaddam, H., Mobarak Abadi, M., Dolatshahi, M., Bayani Ershadi, S., Abbasi-Feijani, F., Rezaei, S., Cattarinussi, G., & Aarabi, M. H. (2021, 2021/08//). Effects of Prenatal Methamphetamine Exposure on the Developing Human Brain: A Systematic Review of Neuroimaging Studies. ACS chemical neuroscience, 12(15), 2729-2748.
    https://doi.org/10.1021/acschemneuro.1c00213
  7. Dolatshahi, M., Ranjbar Hameghavandi, M. H., Sabahi, M., & Rostamkhani, S. (2021, 2021/04/21). Nuclear Factor-Kappa B (NF-κB) in Pathophysiology of Parkinson Disease: Diverse Patterns & Mechanisms Contributing to Neurodegeneration [https://doi.org/10.1111/ejn.15242]. European Journal of Neuroscience, n/a(n/a).
    https://doi.org/https://doi.org/10.1111/ejn.15242 [Epub/ahead of print]
  8. Amanollahi, M., Amanollahi, S., Anjomshoa, A., & Dolatshahi, M.
    (2021, Mar 14). Mitigating the negative impacts of aging on cognitive function; modifiable factors associated with increasing cognitive reserve. Eur J Neurosci.
    https://doi.org/10.1111/ejn.15183
      
  9. Sabahi, M., Joshaghanian, A., Dolatshahi, M., Jabbari, P., Rahmani, F., & Rezaei, N. (2021, Mar 13). Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases. J Mol Neurosci. https://doi.org/10.1007/s12031-021-01818-6

10)  Dolatshahi, M., Sabahi, M., & Aarabi, M. H. (2021, 2021/01/08). Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration. Molecular Neurobiology. https://doi.org/10.1007/s12035-020-02236-2


11)  Sanjari Moghaddam, H., Mohammadi, E.,
Dolatshahi, M., Mohebi, F., Ashrafi, A., Khazaie, H., & Aarabi, M. H. (2021, 2021/03/08/). White matter microstructural abnormalities in primary insomnia: A systematic review of diffusion tensor imaging studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 105, 110132. https://doi.org/https://doi.org/10.1016/j.pnpbp.2020.110132
(The first three authors had equal contribution)


12)  Mohammadi, S., Dolatshahi, M., & Rahmani, F. (2021, 2021/01/01). Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors. Journal of Endocrinological Investigation, 44(1), 1-13. https://doi.org/10.1007/s40618-020-01314-5


13)  Sanjari Moghaddam, H., Doost Hoseini, M., Khaleghi, M. R., Tafakhori, A.,
Dolatshahi, M., Pourmirbabaei, S., Agah, E., Meshkat, S., & Aghamollaii, V. (2020, 2020/09/10). Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment Battery. Behavioural Neurology, 2020, 8710373.
https://doi.org/10.1155/2020/8710373


14)  Sanjari Moghaddam, H.,
Dolatshahi, M., Mohebi, F., & Aarabi, M. H. (2020, Jul). Structural white matter alterations as compensatory mechanisms in Parkinson's disease: A systematic review of diffusion tensor imaging studies. J Neurosci Res, 98(7), 1398-1416.
https://doi.org/10.1002/jnr.24617


15)  Kamalian, A., Sohrabi Asl, M.,
Dolatshahi, M., Afshari, K., Shamshiri, S., Momeni Roudsari, N., Momtaz, S., Rahimi, R., Abdollahi, M., & Abdolghaffari, A. H. (2020, Jun 28). Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol, 26(24), 3365-3400. https://doi.org/10.3748/wjg.v26.i24.3365


16)  Mohammadi, S.,
Dolatshahi, M., Zare-Shahabadi, A., & Rahmani, F. (2019, 2019/09/01/). Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research, 1718, 212-222.
https://doi.org/https://doi.org/10.1016/j.brainres.2019.04.013


17)  Pourmirbabaei, S.,
Dolatshahi, M., & Rahmani, F. (2019, 2019/07/15/). Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia. European Journal of Pharmacology, 855, 149-159.
https://doi.org/https://doi.org/10.1016/j.ejphar.2019.05.004


18)  Sanjari Moghaddam, H.,
Dolatshahi, M., Salardini, E., & Aarabi, M. H. (2019, Feb). Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease. Neurol Sci, 40(2), 283-291.
https://doi.org/10.1007/s10072-018-3629-2


19)  Kheiri, G.,
Dolatshahi, M., Rahmani, F., & Rezaei, N. (2019). Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy. Reviews in the Neurosciences, 30(1), 9-30.
https://doi.org/doi:10.1515/revneuro-2018-0008


20)  Haghshomar, M.,
Dolatshahi, M., Ghazi Sherbaf, F., Sanjari Moghaddam, H., Shirin Shandiz, M., & Aarabi, M. H. (2018, 2018-July-26). Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies [Review]. Frontiers in Neurology, 9(598). https://doi.org/10.3389/fneur.2018.00598


21)  Dolatshahi, M.,Pourmirbabaei, S., Kamalian, A., Ashraf-Ganjouei, A., Yaseri, M., & Aarabi, M. H. (2018, 2018-July-11). Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease [Original Research]. Frontiers in Neurology, 9(560).
https://doi.org/10.3389/fneur.2018.00560


22)  Ansari, M., Rahmani, F.,
Dolatshahi, M., Pooyan, A., & Aarabi, M. H. (2017, Mar). Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder. Sleep Breath, 21(1), 155-161.
https://doi.org/10.1007/s11325-016-1435-8


23)  Anjomshoa, A.,
Dolatshahi, M., Amirkhani, F., Rahmani, F., Mirbagheri, M. M., & Aarabi, M. H. (2016, 16-20 Aug. 2016). Structural brain network analysis in schizophrenia using minimum spanning tree. 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)



Affiliations



  • Iranian Center of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • NeuroImaging Network (NIN), Universal Scientific Research and Education Network (USERN), Tehran, Iran


Ongoing Projects



  1. Conventional MRI-derived Subchondral Trabecular Biomarkers and Their Association with Early Knee Cartilage Volume Loss as Early as 1 Year: A Longitudinal Analysis from Osteoarthritis Initiative (Submitted to
    Skeletal Radiology: Accepted)
  2. Structural white matter changes in patients with migraine using Diffusion Tensor Imaging: A systematic review (Submitted to
    Brain Imaging and Behavior: revision requested)
  3. Combination Therapy in Alzheimer Disease: Is it time? (Submitted to
    Journal of Alzheimer’s disease    : revision requested)
  4. Knee Osteoarthritis-Associated Thigh Muscle MRI Changes and Their Contribution to Clinical Outcome: Osteoarthritis Initiative Data (Submitted to
    Radiology: revision requested )
  5. The alterations of thyroid hormone levels in Alzheimer’s disease: A systematic review and meta-analysis (Submitted to
    Frontiers in Neuroendocrinology: under review)
  6. White matter alterations in type 1 diabetes mellitus using Diffusion Tensor Imaging: A systematic review (Submitted to
    European Radiology: under review)
  7. Statin Use and Longitudinal Changes in Thigh Muscle Quality: An Osteoarthritis Initiative Propensity-Score Matched Study (Submitted to Arthritis & Rheumatology: under review)
  8. Image Segmentation Methods for Automatic Detection of Stroke: A Systematic Review (Under preparation)
  9. Are thyroid hormone disturbances more prevalent in Alzheimer’s disease: A systematic review and meta-analysis (Under preparation)
  10. Imaging Evidence of Cartilage Loss Following Intra-articular Corticosteroid Injection in Knee Osteoarthritis: A Systematic Review and Meta-analysis (Under preparation)











No items yet!

Your experience on this site will be improved by allowing cookies.